NLRP3 and acute kidney injury: In a cisplatin-induced AKI model, SS-31 was found to reduce mitochondrial and intracellular ROS levels, inhibit the expression of downstream NLRP3 vesicles, and improve renal oxidative stress and apoptosis [37].